Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BL, ? 3.3mm NC, SLActive 14mm, TiZr, NTP: medical device reports filed with FDA

633 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

633
device reports naming the brand
0% of all MAUDE reports · about 93 a year
57
reports, 12 months to August 2026
87 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

633 medical device reports received by FDA name the brand "BL, ? 3.3mm NC, SLActive 14mm, TiZr, NTP" (endosseous dental implant); the manufacturer given most often on reports is Institut Straumann; received from September 2019 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

57 reports arrived in the 12 months to August 2026, down 34% from 87 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (67.8%), loss of osseointegration (21.3%) and fracture (2.5%). The patient problems coded most often are fibrosis, pain and tissue damage. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

01121Sep 2021: 9Oct 2021: 7Nov 2021: 10Dec 2021: 92022Jan 2022: 11Feb 2022: 3Mar 2022: 12Apr 2022: 3May 2022: 5Jun 2022: 4Jul 2022: 13Aug 2022: 12Sep 2022: 11Oct 2022: 11Nov 2022: 8Dec 2022: 72023Jan 2023: 4Feb 2023: 5Mar 2023: 7Apr 2023: 9May 2023: 21Jun 2023: 3Jul 2023: 7Aug 2023: 4Sep 2023: 12Oct 2023: 6Nov 2023: 6Dec 2023: 92024Jan 2024: 8Feb 2024: 11Mar 2024: 7Apr 2024: 8May 2024: 3Jun 2024: 3Jul 2024: 11Aug 2024: 7Sep 2024: 12Oct 2024: 7Nov 2024: 13Dec 2024: 52025Jan 2025: 1Feb 2025: 6Mar 2025: 6Apr 2025: 9May 2025: 0Jun 2025: 20Jul 2025: 4Aug 2025: 4Sep 2025: 2Oct 2025: 3Nov 2025: 3Dec 2025: 112026Jan 2026: 4Feb 2026: 4Mar 2026: 2Apr 2026: 8May 2026: 4Jun 2026: 10Jul 2026: 5Aug 2026: 1

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

0531052019: 6520192020: 6820202021: 10520212022: 10020222023: 9320232024: 9520242025: 6920252026: 382026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%633
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report77.1%488
Voluntary report0%0
User facility report0%0
Distributor report22.9%145
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate42967.8%62.8%
Loss of osseointegration13521.3%22.4%
Fracturea broken bone162.5%1.6%
Difficult to insertthe device was hard to insert50.8%0.4%
Difficult to removethe device was hard to remove20.3%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis20031.6%
Painpain, site not specified10015.8%
Tissue damage7111.2%
Inflammationinflammation406.3%
Abscessa collection of pus355.5%
Hemorrhage/blood loss/bleeding294.6%
Swelling/ edema294.6%
Fistula253.9%
Swellingswelling152.4%
Hypersensitivity/allergic reaction81.3%
Failure of implant30.5%
Hyperresponsive to stimuli30.5%
Inadequate osseointegration10.2%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBL, ? 3.3mm NC, SLActive 14mm, TiZr, NTPProduct code DZEAll MAUDE reports
Reports6333,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer77.1%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BL, ? 3.3mm NC, SLActive 14mm, TiZr, NTP reports

How many FDA reports name BL, ? 3.3mm NC, SLActive 14mm, TiZr, NTP?

633 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 57 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (67.8%), loss of osseointegration (21.3%), fracture (2.5%), difficult to insert (0.8%) and difficult to remove (0.3%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (77.1%) and distributor reports (22.9%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BL, ? 3.3mm NC, SLActive 14mm, TiZr, NTP was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.